Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides

K Raynor, WA Murphy, DH Coy, JE Taylor, JP Moreau, K Yasuda, GI Bell and T Reisine

Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia 19104.

The recent molecular cloning of the genes encoding three somatostatin (SRIF) receptor subtypes has allowed for the individual expression of these receptors in mammalian cells and characterization of their respective pharmacological profiles. In the present study, we have investigated the affinities of a battery of SRIF analogues to bind to SRIF receptor subtypes SSTR1 (cloned somatostatin complex), SSTR2, and SSTR3, as well as their abilities to inhibit the release of growth hormone from anterior pituitary cells in vitro. We labeled SSTR1 and SSTR3 receptors expressed in Chinese hamster ovary and COS-1 cells, respectively, with the metabolically stable SRIF analogue 125I-CGP 23996. SSTR2 receptors expressed in Chinese hamster ovary cells were labeled with the SSTR2-specific radioligand 125I-MK-678. Inhibition studies were performed using SRIF analogues of differing structures, including hexapeptide analogues similar to MK-678, octapeptide analogues similar to SMS 201-995, pentapeptide analogues similar to c[Ahep-Phe-D-Trp-Lys-Thr(Bzl)] (SA), and linear SRIF analogues. SSTR1 bound SRIF and SRIF-28 with high affinity and the peptide SA and its structural analogues with low affinity. The hexapeptides did not interact with SSTR1 at concentrations as high as 1 microM, and only a few of the octapeptides or linear peptides bound, with very low affinities. In contrast, 125I-MK-678 binding to SSTR2 was potently inhibited by the hexapeptides, octapeptides, and some of the linear compounds, whereas SA and its analogues did not bind to SSTR2. The potencies of the various SRIF agonists to inhibit growth hormone release in vitro was highly correlated with their potencies to inhibit radioligand binding to SSTR2, but not to SSTR1 or SSTR3. SSTR3 bound analogues of each class but with moderate to low affinities, with the exception of several linear peptides and one of the octapeptides. We report for the first time the binding affinities of linear analogues of SRIF, some of which display subnanomolar affinities and are highly selective for SRIF receptor subtypes. Most importantly, these studies identify several peptide analogues that are highly potent, specific, and selective for individual subtypes of SRIF receptors. Such information, coupled with the knowledge of the distribution of these receptor subtypes in normal and pathological tissues, will be critical for more specific experimental and therapeutic interventions.

Volume 43, Issue 6, pp. 838-844, 06/01/1993
Copyright © 1993 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				G. F Taboada, R. M Luque, L. V. Neto, E. d. O Machado, B. C Sbaffi, R. C Domingues, J. B Marcondes, L. M C Chimelli, R. Fontes, P. Niemeyer, et al. Quantitative analysis of somatostatin receptor subtypes (1-5) gene expression levels in somatotropinomas and correlation to in vivo hormonal and tumor volume responses to treatment with octreotide LAR Eur. J. Endocrinol., March 1, 2008; 158(3): 295 - 303. [Abstract] [Full Text] [PDF]

				G. F Taboada, R. M Luque, W. Bastos, R. F C Guimaraes, J. B Marcondes, L. M C Chimelli, R. Fontes, P. J P Mata, P. N. Filho, D. P Carvalho, et al. Quantitative analysis of somatostatin receptor subtype (SSTR1-5) gene expression levels in somatotropinomas and non-functioning pituitary adenomas Eur. J. Endocrinol., January 1, 2007; 156(1): 65 - 74. [Abstract] [Full Text] [PDF]

				T. Momiyama and L. Zaborszky Somatostatin Presynaptically Inhibits Both GABA and Glutamate Release Onto Rat Basal Forebrain Cholinergic Neurons J Neurophysiol, August 1, 2006; 96(2): 686 - 694. [Abstract] [Full Text] [PDF]

				M. Daunt, O. Dale, and P. A. Smith Somatostatin Inhibits Oxidative Respiration in Pancreatic {beta}-Cells Endocrinology, March 1, 2006; 147(3): 1527 - 1535. [Abstract] [Full Text] [PDF]

				M. Filopanti, C. Ronchi, E. Ballare, S. Bondioni, A. G. Lania, M. Losa, S. Gelmini, A. Peri, C. Orlando, P. Beck-Peccoz, et al. Analysis of Somatostatin Receptors 2 and 5 Polymorphisms in Patients with Acromegaly J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4824 - 4828. [Abstract] [Full Text] [PDF]

				D. Yang, L. Han, and V. Kundra Exogenous Gene Expression in Tumors: Noninvasive Quantification with Functional and Anatomic Imaging in a Mouse Model Radiology, June 1, 2005; 235(3): 950 - 958. [Abstract] [Full Text] [PDF]

				J. R. Grider Neurotransmitters Mediating the Intestinal Peristaltic Reflex in the Mouse J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 460 - 467. [Abstract] [Full Text] [PDF]

				C. Chisholm and G. R. Greenberg Somatostatin-28 regulates GLP-1 secretion via somatostatin receptor subtype 5 in rat intestinal cultures Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E311 - E317. [Abstract] [Full Text] [PDF]

				V. Kundra, F. Mannting, A. G. Jones, and A. I. Kassis Noninvasive Monitoring of Somatostatin Receptor Type 2 Chimeric Gene Transfer J. Nucl. Med., March 1, 2002; 43(3): 406 - 412. [Abstract] [Full Text] [PDF]

				N. Kimura, S. Tomizawa, K. N. Arai, R. Y. Osamura, and N. Kimura Characterization of 5'-Flanking Region of Rat Somatostatin Receptor sst2 Gene: Transcriptional Regulatory Elements and Activation by Pitx1 and Estrogen Endocrinology, April 1, 2001; 142(4): 1427 - 1441. [Abstract] [Full Text]

				C. Chisholm and G. R. Greenberg Somatostatin receptor subtype-5 mediates inhibition of peptide YY secretion from rat intestinal cultures Am J Physiol Gastrointest Liver Physiol, November 1, 2000; 279(5): G983 - G989. [Abstract] [Full Text] [PDF]

				H. Boudin, P. Sarret, J. Mazella, A. Schonbrunn, and A. Beaudet Somatostatin-Induced Regulation of SST2A Receptor Expression and Cell Surface Availability in Central Neurons: Role of Receptor Internalization J. Neurosci., August 15, 2000; 20(16): 5932 - 5939. [Abstract] [Full Text] [PDF]

				V. Martínez, J. Rivier, D. Coy, and Y. Taché Intracisternal Injection of Somatostatin Receptor 5-Preferring Agonists Induces a Vagal Cholinergic Stimulation of Gastric Emptying in Rats J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 1099 - 1105. [Abstract] [Full Text]

				C. Lanneau, M. T. Bluet-Pajot, P. Zizzari, Z. Csaba, P. Dournaud, L. Helboe, D. Hoyer, E. Pellegrini, G. S. Tannenbaum, J. Epelbaum, et al. Involvement of the Sst1 Somatostatin Receptor Subtype in the Intrahypothalamic Neuronal Network Regulating Growth Hormone Secretion: An in Vitro and in Vivo Antisense Study Endocrinology, March 1, 2000; 141(3): 967 - 979. [Abstract] [Full Text] [PDF]

				H. Baumeister, M. Wegner, D. Richter, and W. Meyerhof Dual Regulation Of Somatostatin Receptor Subtype 1 Gene Expression By Pit-1 In Anterior Pituitary GH3 Cells Mol. Endocrinol., February 1, 2000; 14(2): 255 - 271. [Abstract] [Full Text]

				O. C. Palyha, S. D. Feighner, C. P. Tan, K. K. McKee, D. L. Hreniuk, Y.-D. Gao, K. D. Schleim, L. Yang, G. J. Morriello, R. Nargund, et al. Ligand Activation Domain of Human Orphan Growth Hormone (GH) Secretagogue Receptor (GHS-R) Conserved from Pufferfish to Humans Mol. Endocrinol., January 1, 2000; 14(1): 160 - 169. [Abstract] [Full Text]

				D. K. Reed, A. I. Korytko, R. W. Hipkin, W. B. Wehrenberg, A. Schonbrunn, and L. Cuttler Pituitary Somatostatin Receptor (sst)1-5 Expression during Rat Development: Age-Dependent Expression of sst2 Endocrinology, October 1, 1999; 140(10): 4739 - 4744. [Abstract] [Full Text]

				D. J. TORPY, C. C. CHEN, N. MULLEN, J. L. DOPPMAN, J. A. CARRASQUILLO, G. P. CHROUSOS, and L. K. NIEMAN Lack of Utility of 111In-Pentetreotide Scintigraphy in Localizing Ectopic ACTH Producing Tumors: Follow-Up of 18 Patients J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1186 - 1192. [Abstract] [Full Text]

				W. R. Baumbach, T. A. Carrick, M. H. Pausch, B. Bingham, D. Carmignac, I. C. A. F. Robinson, R. Houghten, C. M. Eppler, L. A. Price, and J. R. Zysk A Linear Hexapeptide Somatostatin Antagonist Blocks Somatostatin Activity In Vitro and Influences Growth Hormone Release in Rats Mol. Pharmacol., November 1, 1998; 54(5): 864 - 873. [Abstract] [Full Text]

				S. P. Rohrer, E. T. Birzin, R. T. Mosley, S. C. Berk, S. M. Hutchins, D. Shen, Y. Xiong, E. C. Hayes, R. M. Parmar, F. Foor, et al. Rapid Identification of Subtype-Selective Agonists of the Somatostatin Receptor Through Combinatorial Chemistry Science, October 23, 1998; 282(5389): 737 - 740. [Abstract] [Full Text]

				M. A. Turman and C. A. Apple Human proximal tubular epithelial cells express somatostatin: regulation by growth factors and cAMP Am J Physiol Renal Physiol, June 1, 1998; 274(6): F1095 - F1101. [Abstract] [Full Text] [PDF]

				D. Djordjijevic, J. Zhang, M. Priam, C. Viollet, D. Gourdji, C. Kordon, and J. Epelbaum Effect of 17{beta}-Estradiol on Somatostatin Receptor Expression and Inhibitory Effects on Growth Hormone and Prolactin Release in Rat Pituitary Cell Cultures Endocrinology, May 1, 1998; 139(5): 2272 - 2277. [Abstract] [Full Text] [PDF]

				N. Kimura, S. Tomizawa, K. N. Arai, and N. Kimura Chronic Treatment with Estrogen Up-Regulates Expression of sst2 Messenger Ribonucleic Acid (mRNA) but Down-Regulates Expression of sst5 mRNA in Rat Pituitaries Endocrinology, April 1, 1998; 139(4): 1573 - 1580. [Abstract] [Full Text] [PDF]

				P. Dournaud, H. Boudin, A. Schonbrunn, G. S. Tannenbaum, and A. Beaudet Interrelationships between Somatostatin sst2A Receptors and Somatostatin-Containing Axons in Rat Brain: Evidence for Regulation of Cell Surface Receptors by Endogenous Somatostatin J. Neurosci., February 1, 1998; 18(3): 1056 - 1071. [Abstract] [Full Text] [PDF]

				L. J. Hofland, W. W. de Herder, H. A. Visser-Wisselaar, C. van Uffelen, M. Waaijers, J. Zuyderwijk, P. Uitterlinden, M. J. M. Kros, P. M. van Koetsveld, and S. W. J. Lamberts Dissociation between the Effects of Somatostatin (SS) and Octapeptide SS-Analogs on Hormone Release in a Small Subgroup of Pituitary- and Islet Cell Tumors J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 3011 - 3018. [Abstract] [Full Text] [PDF]

				L. E. Smith, J. J. Kopchick, W. Chen, J. Knapp, F. Kinose, D. Daley, E. Foley, R. G. Smith, and J. M. Schaeffer Essential Role of Growth Hormone in Ischemia-Induced Retinal Neovascularization Science, June 13, 1997; 276(5319): 1706 - 1709. [Abstract] [Full Text]

				S. Boehm and H. Betz Somatostatin Inhibits Excitatory Transmission at Rat Hippocampal Synapses via Presynaptic Receptors J. Neurosci., June 1, 1997; 17(11): 4066 - 4075. [Abstract] [Full Text] [PDF]

				K. Aurang, J. Wang, and K. C. K. Lloyd Somatostatin Inhibition of Acid and Histamine Release by Activation of Somatostatin Receptor Subtype 2 Receptors in Rats J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 245 - 252. [Abstract] [Full Text]

				D. Nouel, G. Gaudriault, M. Houle, T. Reisine, J.-P. Vincent, J. Mazella, and A. Beaudet Differential Internalization of Somatostatin in COS-7 Cells Transfected with SST1 and SST2 Receptor Subtypes: A Confocal Microscopic Study Using Novel Fluorescent Somatostatin Derivatives Endocrinology, January 1, 1997; 138(1): 296 - 306. [Abstract] [Full Text] [PDF]

				F. Viana and B. Hille Modulation of High Voltage-Activated Calcium Channels by Somatostatin in Acutely Isolated Rat Amygdaloid Neurons J. Neurosci., October 1, 1996; 16(19): 6000 - 6011. [Abstract] [Full Text] [PDF]

				G. Liapakis, D. Fitzpatrick, C. Hoeger, J. Rivier, R. Vandlen, and T. Reisine Identification of Ligand Binding Determinants in the Somatostatin Receptor Subtypes 1and 2 J. Biol. Chem., August 23, 1996; 271(34): 20331 - 20339. [Abstract] [Full Text] [PDF]

				H. Baumeister and W. Meyerhof The POU Domain Transcription Factor Tst-1 Activates Somatostatin Receptor 1 Gene Expression in Pancreatic beta -Cells J. Biol. Chem., September 8, 2000; 275(37): 28882 - 28887. [Abstract] [Full Text] [PDF]